Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

13 results

Sort by

List item

Human medicine European public assessment report (EPAR): Arepanrix

split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs., Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 23/03/2010, , Revision: 1, Withdrawn, Last updated: 25/10/2011
List item

Human medicine European public assessment report (EPAR): ATryn

Antithrombin alfa, Antithrombin III Deficiency
Date of authorisation: 28/07/2006, , , Revision: 16, Withdrawn, Last updated: 02/07/2019
List item

Human medicine European public assessment report (EPAR): Daronrix

Whole virion, inactivated, containing antigen*: A/Vietnam/1194/2004 (H5N1)* produced in eggs, Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 21/03/2007, , Withdrawn, Last updated: 02/07/2013
List item

Human medicine European public assessment report (EPAR): Glybera

alipogene tiparvovec, Hyperlipoproteinemia Type I
Date of authorisation: 25/10/2012, , , Revision: 8, Withdrawn, Last updated: 30/10/2017
List item

Human medicine European public assessment report (EPAR): Humenza

split influenza virus, inactivated, containing antigen*: A/California/7/2009 (H1N1)v like strain (X-179A)*propagated in eggs., Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 08/06/2010, , Withdrawn, Last updated: 30/06/2011
List item

Human medicine European public assessment report (EPAR): Kolbam

cholic acid, Metabolism, Inborn Errors
Date of authorisation: 20/11/2015, , Revision: 14, Withdrawn, Last updated: 15/07/2020
List item

Human medicine European public assessment report (EPAR): Lartruvo

Olaratumab, Sarcoma
Date of authorisation: 09/11/2016, , , , Revision: 3, Withdrawn, Last updated: 02/09/2019
List item

Human medicine European public assessment report (EPAR): Onsenal

Celecoxib, Adenomatous Polyposis Coli
Date of authorisation: 17/10/2003, , Revision: 13, Withdrawn, Last updated: 06/04/2011
List item

Human medicine European public assessment report (EPAR): Pumarix

pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) , Influenza, Human; Immunization; Disease Outbreaks
Date of authorisation: 04/03/2011, , Revision: 4, Withdrawn, Last updated: 17/03/2015
List item

Human medicine European public assessment report (EPAR): Rilonacept Regeneron (previously Arcalyst)

Rilonacept, Cryopyrin-Associated Periodic Syndromes
Date of authorisation: 23/10/2009, , Revision: 5, Withdrawn, Last updated: 30/10/2012
List item

Human medicine European public assessment report (EPAR): Xigris

drotrecogin alfa (activated), Sepsis; Multiple Organ Failure
Date of authorisation: 22/08/2002, , Revision: 13, Withdrawn, Last updated: 21/02/2012
List item

Human medicine European public assessment report (EPAR): Zalmoxis

Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2), Hematopoietic Stem Cell Transplantation; Graft vs Host Disease
Date of authorisation: 18/08/2016, , Revision: 1, Withdrawn, Last updated: 14/02/2020
List item

Human medicine European public assessment report (EPAR): Zynteglo

Autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019, , , , , Revision: 5, Withdrawn, Last updated: 30/11/2022